GB201617723D0 - Method for predicting prostate cancer metastasis - Google Patents

Method for predicting prostate cancer metastasis

Info

Publication number
GB201617723D0
GB201617723D0 GBGB1617723.0A GB201617723A GB201617723D0 GB 201617723 D0 GB201617723 D0 GB 201617723D0 GB 201617723 A GB201617723 A GB 201617723A GB 201617723 D0 GB201617723 D0 GB 201617723D0
Authority
GB
United Kingdom
Prior art keywords
prostate cancer
cancer metastasis
predicting prostate
predicting
metastasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1617723.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary University of London filed Critical Queen Mary University of London
Priority to GBGB1617723.0A priority Critical patent/GB201617723D0/en
Publication of GB201617723D0 publication Critical patent/GB201617723D0/en
Priority to PCT/EP2017/076786 priority patent/WO2018073382A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
GBGB1617723.0A 2016-10-19 2016-10-19 Method for predicting prostate cancer metastasis Ceased GB201617723D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1617723.0A GB201617723D0 (en) 2016-10-19 2016-10-19 Method for predicting prostate cancer metastasis
PCT/EP2017/076786 WO2018073382A1 (en) 2016-10-19 2017-10-19 Method for predicting prostate cancer metastasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1617723.0A GB201617723D0 (en) 2016-10-19 2016-10-19 Method for predicting prostate cancer metastasis

Publications (1)

Publication Number Publication Date
GB201617723D0 true GB201617723D0 (en) 2016-11-30

Family

ID=57680827

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1617723.0A Ceased GB201617723D0 (en) 2016-10-19 2016-10-19 Method for predicting prostate cancer metastasis

Country Status (2)

Country Link
GB (1) GB201617723D0 (en)
WO (1) WO2018073382A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150262C (en) 1992-12-04 2008-07-08 Kaspar-Philipp Holliger Multivalent and multispecific binding proteins, their manufacture and use
US5427663A (en) 1993-06-08 1995-06-27 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
US6692952B1 (en) 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
AU2003277153A1 (en) 2002-09-27 2004-04-19 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
DE60332046D1 (en) 2002-10-23 2010-05-20 Univ Princeton CONTINUOUS PARTICLE SEPARATION METHOD USING FIELD ASYMMETRICALLY LOCATED OBSTACLE ARRAYS
EP1636564A1 (en) 2003-06-13 2006-03-22 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
US20130171642A1 (en) * 2011-12-30 2013-07-04 Ventana Medical Systems, Inc. Automated analysis of circulating tumor cells
CN105102978B (en) * 2013-02-02 2018-11-02 杜克大学 The method for detaching circulating tumor cell
US9631179B2 (en) 2013-03-15 2017-04-25 Angle North America, Inc. Methods for segregating particles using an apparatus with a size-discriminating separation element having an elongate leading edge
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card
WO2016049658A1 (en) * 2014-09-26 2016-03-31 The Regents Of The University Of California Method of assessing disease condition of cancer

Also Published As

Publication number Publication date
WO2018073382A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
IL304252A (en) Method for treating cancer
IL289947A (en) Method for treating cancer
HK1247276A1 (en) Biomarkers for pancreatic cancer
IL251141A0 (en) A method of predicting risk of recurrence of cancer
GB201500584D0 (en) Cancer biomarkers
SG11201701875YA (en) Methods for detecting ovarian cancer
EP3410118A4 (en) Prostate carcinoma determination method
HK1250257A1 (en) Biomarker combinations for prostate disease
GB201517028D0 (en) Novel biomarkers for pancreatic cancer
GB201418242D0 (en) Genetic biomarkers and method for evaluating cancers
HK1249134A1 (en) Biomarkers for colorectal cancer related diseases
IL259661A (en) Biomarkers for treating cancer with apilimod
EP3093343A4 (en) Method for assessing lymph node metastatic potential of endometrial cancer
IL257514A (en) Cancer detection method
IL265537A (en) Methods for treating ovarian cancer
EP3332037A4 (en) Methods for predicting prostate cancer relapse
GB201617723D0 (en) Method for predicting prostate cancer metastasis
EP3470528A4 (en) Method for predicting effect of pharmacotherapy on cancer
GB201617722D0 (en) Method for determining prognosis of cancer
SG11201608328RA (en) Method for predicting response to therapy for cancer
GB201506666D0 (en) Biomarkers for prostate cancer
GB201703640D0 (en) Prostate cancer biomarkers
EP3564665A4 (en) Ex-vivo method for the prognosis of metastasis in prostate cancer
GB201600329D0 (en) Biomarker panel for prostate cancer
GB201700289D0 (en) Biomarker panel for prostate cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)